The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Boer, R. J.
Right arrow Articles by Perelson, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Boer, R. J.
Right arrow Articles by Perelson, A. S.
The Journal of Immunology, 2003, 171: 3928-3935.
Copyright © 2003 by The American Association of Immunologists

Different Dynamics of CD4+ and CD8+ T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection 1

Rob J. De Boer2,*, Dirk Homann{dagger} and Alan S. Perelson{ddagger}

* Theoretical Biology, Utrecht University, Utrecht, The Netherlands; {dagger} Department of Neuropharmacology, Division of Virology, The Scripps Research Institute, La Jolla, CA 92037; and {ddagger} Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545.

We fit a mathematical model to data characterizing the primary cellular immune response to lymphocytic choriomeningitis virus. The data enumerate the specific CD8+ T cell response to six MHC class I-restricted epitopes and the specific CD4+ T cell responses to two MHC class II-restricted epitopes. The peak of the response occurs around day 8 for CD8+ T cells and around day 9 for CD4+ T cells. By fitting a model to the data, we characterize the kinetic differences between CD4+ and CD8+ T cell responses and among the immunodominant and subdominant responses to the various epitopes. CD8+ T cell responses have faster kinetics in almost every aspect of the response. For CD8+ and CD4+ T cells, the doubling time during the initial expansion phase is 8 and 11 h, respectively. The half-life during the contraction phase following the peak of the response is 41 h and 3 days, respectively. CD4+ responses are even slower because their contraction phase appears to be biphasic, approaching a 35-day half-life 8 days after the peak of the response. The half-life during the memory phase is 500 days for the CD4+ T cell responses and appears to be lifelong for the six CD8+ T cell responses. Comparing the responses between the various epitopes, we find that immunodominant responses have an earlier and/or larger recruitment of precursors cells before the expansion phase and/or have a faster proliferation rate during the expansion phase.




This article has been cited by other articles:


Home page
BioinformaticsHome page
C. Lundegaard, O. Lund, C. Kesmir, S. Brunak, and M. Nielsen
Modeling the adaptive immune system: predictions and simulations
Bioinformatics, December 15, 2007; 23(24): 3265 - 3275.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. V. Ganusov
Discriminating between Different Pathways of Memory CD8+ T Cell Differentiation
J. Immunol., October 15, 2007; 179(8): 5006 - 5013.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. L. Althaus, V. V. Ganusov, and R. J. De Boer
Dynamics of CD8+ T Cell Responses during Acute and Chronic Lymphocytic Choriomeningitis Virus Infection
J. Immunol., September 1, 2007; 179(5): 2944 - 2951.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
D. Milutinovic and R. J. De Boer
Process Noise: An Explanation for the Fluctuations in the Immune Response during Acute Viral Infection
Biophys. J., May 15, 2007; 92(10): 3358 - 3367.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. D. Hawkins, M. L. Turner, M. R. Dowling, C. van Gend, and P. D. Hodgkin
A model of immune regulation as a consequence of randomized lymphocyte division and death times
PNAS, March 20, 2007; 104(12): 5032 - 5037.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. R. Regoes, D. L. Barber, R. Ahmed, and R. Antia
Estimation of the rate of killing by cytotoxic T lymphocytes in vivo
PNAS, January 30, 2007; 104(5): 1599 - 1603.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. K. Whitmire, N. Benning, and J. L. Whitton
Precursor Frequency, Nonlinear Proliferation, and Functional Maturation of Virus-Specific CD4+ T Cells.
J. Immunol., March 1, 2006; 176(5): 3028 - 3036.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. T. M. Vossen, M.-R. Gent, K. M. C. Peters, P. M. E. Wertheim-van Dillen, K. M. Dolman, A. van Breda, R. A. W. van Lier, and T. W. Kuijpers
Persistent Detection of Varicella-Zoster Virus DNA in a Previously Healthy Child after Severe Chickenpox
J. Clin. Microbiol., November 1, 2005; 43(11): 5614 - 5621.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. M. Haeryfar, R. J. DiPaolo, D. C. Tscharke, J. R. Bennink, and J. W. Yewdell
Regulatory T Cells Suppress CD8+ T Cell Responses Induced by Direct Priming and Cross-Priming and Moderate Immunodominance Disparities
J. Immunol., March 15, 2005; 174(6): 3344 - 3351.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Pepper, F. Dzierszinski, A. Crawford, C. A. Hunter, and D. Roos
Development of a System To Study CD4+-T-Cell Responses to Transgenic Ovalbumin-Expressing Toxoplasma gondii during Toxoplasmosis
Infect. Immun., December 1, 2004; 72(12): 7240 - 7246.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Z. Wang, M. A. Brehm, and R. M. Welsh
Preapoptotic Phenotype of Viral Epitope-Specific CD8 T Cells Precludes Memory Development and Is an Intrinsic Property of the Epitope
J. Immunol., October 15, 2004; 173(8): 5138 - 5147.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. H. Doody, J. T. Kovalchin, M. A. Mihalyo, A. T. Hagymasi, C. G. Drake, and A. J. Adler
Glycoprotein 96 Can Chaperone Both MHC Class I- and Class II-Restricted Epitopes for In Vivo Presentation, but Selectively Primes CD8+ T Cell Effector Function
J. Immunol., May 15, 2004; 172(10): 6087 - 6092.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.